Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 63Colonic Neoplasms 29Rectal Neoplasms 25Neoplasm Metastasis 11Stomach Neoplasms 8Carcinoma, Hepatocellular 7Pancreatic Neoplasms 6Neoplasms 6Esophageal Neoplasms 4Adenocarcinoma Of Esophagus 4Liver Neoplasms 3Ovarian Neoplasms 2Esophageal Squamous Cell Carcinoma 2Recurrence 1Prostatic Neoplasms 1Postoperative Complications 1Peritoneal Neoplasms 1Operable T2-3N+M0 Rectal Cancer (Stage III) 1Neuropathy, Painful 1Neuralgia 1Neoplasm Recurrence, Local 1Melanoma 1Malignant Solid Tumour 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Gastrointestinal Neoplasms 1Cold Hypersensitivity 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 1nintedanib 1dactolisib 1avelumab 1Vorinostat 1Sunitinib 1Oxaliplatin 1Levoleucovorin 1Leucovorin 1Hydroxychloroquine 1Folfox protocol 1Fluorouracil 1Dasatinib 1DOXO-EMCH 1Cetuximab 1Bevacizumab 1BN 80927 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Malignant Solid Tumour × Folfox protocol × Clear all
NCT01611857 2016-11-23

Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach

SCRI Development Innovations, LLC

Phase 1/2 Completed
49 enrolled 12 charts
GastrointestinalOther solid neoplasm

Malignant Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡